Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 5:60:15-23.
doi: 10.1016/j.euros.2023.12.005. eCollection 2024 Feb.

Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial

Affiliations

Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial

Thomas van Doeveren et al. Eur Urol Open Sci. .

Abstract

Background and objective: The possible negative impact of radical surgery on patients' health-related quality of life (HRQoL) plays an important role in preoperative counseling. Here, we analyzed the HRQoL of patients treated for upper urinary tract urothelial carcinoma (UTUC) in the context of a single-arm phase 2 multicenter study, in which the safety and efficacy of a single preoperative intravesical instillation with mitomycin C were investigated. Our objective was to investigate early changes in HRQoL in patients undergoing radical surgery for UTUC and identify factors associated with these outcomes.

Methods: Patients with pTanyN0-1M0 UTUC were prospectively included. HRQoL was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) questionnaire at baseline, and at 1 and 3 mo after surgery. A linear mixed model was used to evaluate the changes in HRQoL over time and identify the variables associated with these outcomes. The clinical effect size was used to assess the clinical impact and level of perceptibility of HRQoL changes for clinicians and/or patients based on given thresholds.

Key findings and limitations: Between 2017 and 2020, 186 patients were included. At baseline, 1 mo after surgery, and 3 mo after surgery, response rates were 91%, 84%, and 78%, respectively. One month after surgery, a statistically significant and clinically relevant deterioration was observed in physical, role, and social functioning, and for the included symptom scales: constipation, fatigue, and pain. An improvement in emotional functioning was observed. At 3 mo, HRQoL returned to baseline levels, except emotional functioning, which improved at 1 mo and persisted to be better than that before surgery. Age >70 yr was associated with worse physical functioning, but better social and emotional functioning. Male patients reported better emotional functioning than females. Postoperative complications were negatively associated with social functioning.

Conclusions and clinical implications: UTUC patients treated with radical surgery experienced a significant, albeit temporary, decline in HRQoL. Three months following surgery, HRQoL outcomes returned to baseline levels. This information can be used to counsel UTUC patients before undergoing radical surgery and contextualize recovery after surgery.

Patient summary: We investigated the changes in quality of life as reported by patients who underwent surgery for upper tract urothelial carcinoma (UTUC). We found that patients experienced a decline in quality of life 1 mo after surgery, but this was temporary, with full recovery of quality of life 3 mo after surgery. These findings can help doctors and other medical staff in counseling UTUC patients before undergoing radical surgery.

Keywords: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30; Health-related quality of life; Radical surgery; Short term; Upper urinary tract; Urothelial carcinoma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow diagram of the REBACARE HRQoL study. Responders answered all the questions. HRQoL = health-related quality of life.
Fig. 2
Fig. 2
Mean scores at baseline, and at 1 and 3 mo after radical surgery for all functional scales of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 for male versus female UTUC patients. Scores were adjusted for age, pT stage, age-adjusted CCI, surgical complication, type of surgery, and lymph node dissection using a linear mixed model analysis. CCI = Charlson Comorbidity Index; EORTC QLQ-C30 = European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30; UTUC = upper tract urothelial carcinoma.

References

    1. Roupret M., Seisen T., Birtle A.J., et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol. 2023;84:49–64. - PubMed
    1. Almas B., Halvorsen O.J., Johannesen T.B., Beisland C. Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study. World J Urol. 2021;39:3385–3391. - PMC - PubMed
    1. Eylert M.F., Hounsome L., Verne J., Bahl A., Jefferies E.R., Persad R.A. Prognosis is deteriorating for upper tract urothelial cancer: data for England 1985–2010. BJU Int. 2013;112:E107–E113. - PubMed
    1. van Doeveren T., van der Mark M., van Leeuwen P.J., Boormans J.L., Aben K.K.H. Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population-based study from 1993 to 2017. BJU Int. 2021;128:343–351. - PMC - PubMed
    1. Birtle A., Johnson M., Chester J., et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. 2020;395:1268–1277. - PMC - PubMed

LinkOut - more resources